Metabolism of glucose and glutamine in lymphocytes from graves' hyperthyroid patients: influence of methimazole treatment

This publication has 35 references indexed in Scilit:

• Inhibition of Functional and Immunological Responses to Thyroid-Stimulating Antibodies from Patients with Graves' Disease by Blockade of the Thyrotropin Receptor
  Thyroid®, 1993
• Has the Use of Antithyroid Drugs for Graves' Disease Become Obsolete?
  Thyroid®, 1993
• Suppressor T Lymphocyte Dysfunction Is Important in the Pathogenesis of Autoimmune Thyroid Disease: A Perspective
  Thyroid®, 1993
• Circulating activated T cell subsets in autoimmune thyroid diseases: Differences between untreated and treated patients
  Acta Endocrinologica, 1991
• Administration of Thyroxine in Treated Graves' Disease
  New England Journal of Medicine, 1991
• Lasting Remissions in Patients Treated for Graves’ Hyperthyroidism With Propranolol Alone: A Pattern of Spontaneous Evolution of the Disease*
  Journal of Clinical Endocrinology & Metabolism, 1988
• Methimazole blocks Graves' IgG but not interferon-γ HLA-DR expression by thyroid cells
  Immunology Letters, 1988
• Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*
  Journal of Clinical Endocrinology & Metabolism, 1983
• Carbimazole and the Autoimmune Response in Graves' Disease
  New England Journal of Medicine, 1980
• Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' Disease
  Annals of Internal Medicine, 1980